Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Artivion, Inc. Common Stock (NY: AORT )

30.99 +0.40 (+1.31%)
Official Closing Price Updated: 7:00 PM EST, Feb 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Artivion, Inc. Common Stock

< Previous 1 2 Next >
This Senator Just Bought Up To $100K In Artivion Stock
The Office of Senator Tina Smith reported a purchase of Artivion (NYSE:AORT) stock on October 17, 2022. According to the October filing, the transaction was made on October 17, 2022. 
Via Benzinga
This Analyst Says Artivion's Sell Off Seems Overdone After Trial Halt
Via Benzinga
Oppenheimer Maintains Outperform Rating for Artivion: Here's What You Need To Know
Oppenheimer has decided to maintain its Outperform rating of Artivion (NYSE:AORT) and lower its price target from $35.00 to $25.00. Shares of Artivion are trading up 1.43% over the last 24 hours, at... 
Via Benzinga
4 Analysts Have This to Say About Artivion
Artivion (NYSE:AORT) has observed the following analyst ratings within the last quarter: 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers 
Via Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $600 Today
Artivion (NYSE:AORT) has outperformed the market over the past 20 years by 1.64% on an annualized basis producing an average annual return of 9.19%. Currently, Artivion has a market capitalization of... 
Via Benzinga
Artivion Stock Plunges Apixaban Vs. Warfarin Trial Setback, Reaffirms Annual Guidance
Via Benzinga
Earnings Scheduled For February 17, 2022
Companies Reporting Before The Bell • Palantir Technologies (NYSE:PLTR) is estimated to report quarterly earnings at $0.04 per share on revenue of $417.69 million. 
Via Benzinga
Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday
Gainers Golden Sun Education Group Limited (NASDAQ: GSUN) shares surged 92.1% to settle at $52.89 on Friday. 
Via Benzinga
Why Shares Of Oil & Gas Companies Are Trading Lower, Here Are 62 Stocks Moving In Friday's Mid-Day Session
Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) shares jumped 87% to $0.4791. Kiromic BioPharma, said on Sept. 15, that the company received letter from the Nasdaq that co. has been granted 180-day... 
Via Benzinga
US Stocks Open Lower; Dow Tumbles 400 Points
U.S. stocks traded lower this morning, with the Dow Jones dropping around 400 points on Friday. 
Via Benzinga
Artivion: Q2 Earnings Insights
Artivion (NYSE:AORT) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Artivion beat estimated earnings by... 
Via Benzinga
Recap of Wednesday's Biotech Catalysts - End of The Day Summary
Via Benzinga
Stocks That Hit 52-Week Highs On Thursday
On Thursday, 75 stocks made new 52-week highs. Interesting Highlights From Today's 52-Week Highs: The largest company by market cap to hit a new 52-week high... 
Via Benzinga
Stocks That Hit 52-Week Highs On Thursday
On Thursday, 95 companies set new 52-week highs. Interesting Highlights From Today's 52-Week Highs: The largest company by market cap to break to a new 52-week high... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2022
Upgrades For Douglas Emmett Inc (NYSE:DEI), Evercore ISI Group upgraded the previous rating of In-Line to Outperform. For the fourth quarter, Douglas Emmett had an EPS of $0.48,... 
Via Benzinga
Recap: Artivion Q4 Earnings
Artivion (NYSE:AORT) reported its Q4 earnings results on Thursday, February 17, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Artivion missed estimated earnings... 
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.